p53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels

Cell Death and Differentiation

Volumn 13, Issue 12, 2006, Pages 2118-2128

  Zhang, J ^a   Yan, W ^a   Chen, X ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME REGULATION; GENE OVEREXPRESSION; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NEURONS; PC12 CELLS; RATS; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33751020831     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401972     Document Type: Article

References (38)

1. Wallingford JB, Seufert DW, Virta VC and Vize PD (1997) p53 activity is essential for normal development in Xenopus. Curr. Biol. 7: 747-757.
2. Huang EJ and Reichardt LF (2003) Trk receptors: Roles in neuronal signal transduction. Annu. Rev. Biochem. 72: 609-642.
3. Tischler AS and Greene LA (1975) Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells. Nature 258: 341-342.
4. Harms K, Nozell S and Chen X (2004) The common and distinct target genes of the p53 family transcription factors. Cell Mol. Life Sci. 61: 822-842.
5. Ko LJ and Prives C (1996) p53: Puzzle and paradigm. Genes Dev. 10: 1054-1072.
6. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
7. Abarzua P, LoSardo JE, Gubler ML and Neri A (1995) Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53. Cancer Res. 55: 3490-3494.
8. Miller FD, Pozniak CD and Walsh GS (2000) Neuronal life and death: An essential role for the p53 family. Cell Death Differ. 7: 880-888.
9. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT and Jacks T (1995) A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10: 175-180.
10. Eizenberg O, Faber-Elman A, Gottlieb E, Oren M, Rotter V and Schwartz M (1996) p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell Biol. 16: 5178-5185.
11. Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, Chin DM, Bacus SS, Stark GR and Gudkov AV (1997) Transgenic mice with p53-responsive lacZ: P53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 16: 1391-1400.
12. Tokumoto YM, Tang DG and Raff MC (2001) Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: Role of a p53 family protein. EMBO J. 20: 5261-5268.
13. Hughes AL, Gollapudi L, Sladek TL and Neet KE (2000) Mediation of nerve growth factor-driven cell cycle arrest in PC12 cells by p53. Simultaneous differentiation and proliferation subsequent to p53 functional inactivation. J. Biol. Chem. 275: 37829-37837.
14. Ferreira A and Kosik KS (1996) Accelerated neuronal differentiation induced by p53 suppression. J. Cell Sci. 109 (Part 6): 1509-1516.
15. Gollapudi L and Neet KE (1997) Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine. J. Neurosci. Res. 49: 461-474.
16. Schrama LH, Lepperdinger G, Moritz A, van den Engel NK, Marquart A, Oestreicher AB, Eggen BJ, Hage WJ, Richter K and Destree OH (1997) B-50/ growth-associated protein-43, a marker of neural development in Xenopus laevis. Neuroscience 76: 635-652.
17. Michalovitz D, Halevy O and Oren M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671-680.
18. Qui MS and Green SH (1992) PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9: 705-717.
19. Levkovitz Y, O'Donovan KJ and Baraban JM (2001) Blockade of NGF-induced neurite outgrowth by a dominant-negative inhibitor of the egr family of transcription regulatory factors. J. Neurosci. 21: 45-52.
20. Obermeier A, Lammers R, Wiesmuller KH, Jung G, Schlessinger J and Ullrich A (1993) Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex. J. Biol. Chem. 268: 22963-22966.
21. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N and Liu EA (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303: 844-848.
22. Lavenius E, Gestblom C, Johansson I, Nanberg E and Pahlman S (1995) Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Cell Growth Differ. 6: 727-736.
23. Poluha W, Poluha DK and Ross AH (1995) TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene 10: 185-189.
24. Bargonetti J, Friedman PN, Kern SE, Vogelstein B and Prives C (1991) Wildtype but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell 65: 1083-1091.
25. Loeb DM, Maragos J, Martin-Zanca D, Chao MV, Parada LF and Greene LA (1991) The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell 66: 961-966.
26. Hempstead BL, Rabin SJ, Kaplan L, Reid S, Parada LF and Kaplan DR (1992) Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation. Neuron 9: 883-896.
27. Mobarak CD, and erson KD, Morin M, Beckel-Mitchener A, Rogers SL, Furneaux H, King P and Perrone-Bizzozero NI (2000) The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells. Mol. Biol. Cell. 11: 3191-3203.
28. Kaplan DR and Miller FD (1997) Signal transduction by the neurotrophin receptors. Curr. Opin. Cell Biol. 9: 213-221.
29. Yan C, Liang Y, Nyland er KD and Schor NF (2002) TrkA as a life and death receptor: Receptor dose as a mediator of function. Cancer Res. 62: 4867-4875.
30. Lavoie JF, Lesauteur L, Kohn J, Wong J, Furtoss O, Thiele CJ, Miller FD and Kaplan DR (2005) TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. J. Biol. Chem. 280: 29199-29207.
31. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB and Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 328: 847-854.
32. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA and Barbacid M (1994) Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368: 246-249.
33. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
34. Armstrong JF, Kaufman MH, Harrison DJ and Clarke AR (1995) Highfrequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5: 931-936.
35. Harms KL and Chen X (2005) The C terminus of p53 family proteins is a cell fate determinant. Mol. Cell Biol. 25: 2014-2030.
36. Chen X, Farmer G, Zhu H, Prywes R and Prives C (1993) Cooperative DNA binding of p53 with TFIID (TBP): A possible mechanism for transcriptional activation [published erratum appears in Genes Dev 1993 Dec;7(12B):2652]. Genes Dev. 7: 1837-1849.
37. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C and Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252: 1708-1711.
38. Bargonetti J, Reynisdottir I, Friedman PN and Prives C (1992) Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40T antigen and mutant p53. Genes Dev. 6: 1886-1898.